We	PRP	OTHER	O 0 2	[1]	[2]	CAPITALIZED	allAlpha
have	VBP	VP	O 3 7	[2]	[4]	LOWERCASE	allAlpha
demonstrated	VBN	VP	O 8 20	[3]	[12]	LOWERCASE	allAlpha
a	DT	OTHER	O 21 22	[4]	[1]	LOWERCASE	allAlpha
new	JJ	NP	O 23 26	[5]	[3]	LOWERCASE	allAlpha
approach	NN	NP	O 27 35	[6]	[8]	LOWERCASE	allAlpha
to	TO	OTHER	O 36 38	[7]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 39 42	[8]	[3]	LOWERCASE	allAlpha
manufacture	NN	NP	B-T 43 54	[9]	[11]	LOWERCASE	allAlpha
of	IN	PP	I-T 55 57	[10]	[2]	LOWERCASE	allAlpha
self-folding	JJ	NP	B-M 58 70	[11]	[12]	LOWERCASE	ContainSymbol
hydrogel	NN	NP	I-M 71 79	[12]	[8]	LOWERCASE	allAlpha
scaffolds	NNS	NP	I-M 80 89	[13]	[9]	LOWERCASE	allAlpha
by	IN	OTHER	O 90 92	[14]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 93 96	[15]	[3]	LOWERCASE	allAlpha
use	NN	NP	O 97 100	[16]	[3]	LOWERCASE	allAlpha
of	IN	PP	O 101 103	[17]	[2]	LOWERCASE	allAlpha
readily	RB	OTHER	B-P 104 111	[18]	[7]	LOWERCASE	allAlpha
available	JJ	OTHER	I-P 112 121	[19]	[9]	LOWERCASE	allAlpha
and	CC	OTHER	I-P 122 125	[20]	[3]	LOWERCASE	allAlpha
fast	JJ	NP	I-P 126 130	[21]	[4]	LOWERCASE	allAlpha
throughput	NN	NP	I-P 131 141	[22]	[10]	LOWERCASE	allAlpha
methods.	NN	NP	I-P 142 149	[23]	[8]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 151 154	[1]	[3]	CAPITALIZED	allAlpha
process	NN	NP	O 155 162	[2]	[7]	LOWERCASE	allAlpha
shows	VBZ	VP	O 163 168	[3]	[5]	LOWERCASE	allAlpha
effective	JJ	NP	B-P 169 178	[4]	[9]	LOWERCASE	allAlpha
pattern	NN	NP	I-P 179 186	[5]	[7]	LOWERCASE	allAlpha
transfer	NN	NP	I-P 187 195	[6]	[8]	LOWERCASE	allAlpha
by	IN	OTHER	O 196 198	[7]	[2]	LOWERCASE	allAlpha
first	RB	OTHER	O 199 204	[8]	[5]	LOWERCASE	allAlpha
embossing	VBG	VP	B-P 205 214	[9]	[9]	LOWERCASE	allAlpha
a	DT	OTHER	I-P 215 216	[10]	[1]	LOWERCASE	allAlpha
sacrificial	JJ	NP	I-P 217 228	[11]	[11]	LOWERCASE	allAlpha
layer	NN	NP	I-P 229 234	[12]	[5]	LOWERCASE	allAlpha
and	CC	OTHER	O 235 238	[13]	[3]	LOWERCASE	allAlpha
using	VBG	VP	B-P 239 244	[14]	[5]	LOWERCASE	allAlpha
it	PRP	OTHER	I-P 245 247	[15]	[2]	LOWERCASE	allAlpha
as	IN	OTHER	I-P 248 250	[16]	[2]	LOWERCASE	allAlpha
a	DT	OTHER	I-P 251 252	[17]	[1]	LOWERCASE	allAlpha
soluble	JJ	NP	B-M 253 260	[18]	[7]	LOWERCASE	allAlpha
mould	NN	NP	I-M 261 266	[19]	[5]	LOWERCASE	allAlpha
in	IN	OTHER	I-P 267 269	[20]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	I-P 270 273	[21]	[3]	LOWERCASE	allAlpha
fabrication	NN	NP	B-P 274 285	[22]	[11]	LOWERCASE	allAlpha
process.	NN	NP	I-P 286 293	[23]	[8]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 295 298	[1]	[3]	CAPITALIZED	allAlpha
use	NN	NP	O 299 302	[2]	[3]	LOWERCASE	allAlpha
of	IN	PP	O 303 305	[3]	[2]	LOWERCASE	allAlpha
a	DT	OTHER	O 306 307	[4]	[1]	LOWERCASE	allAlpha
sacrificial	JJ	NP	B-M 308 319	[5]	[11]	LOWERCASE	allAlpha
layer	NN	NP	I-M 320 325	[6]	[5]	LOWERCASE	allAlpha
of	IN	PP	I-M 326 328	[7]	[2]	LOWERCASE	allAlpha
PAA	NN	NP	I-M 329 332	[8]	[3]	CAPITALIZED	allAlpha
imparts	VBZ	VP	O 333 340	[9]	[7]	LOWERCASE	allAlpha
environmental	JJ	NP	O 341 354	[10]	[13]	LOWERCASE	allAlpha
sensitivity	NN	NP	O 355 366	[11]	[11]	LOWERCASE	allAlpha
to	TO	OTHER	O 367 369	[12]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 370 373	[13]	[3]	LOWERCASE	allAlpha
hydrogel	NN	NP	B-M 374 382	[14]	[8]	LOWERCASE	allAlpha
film	NN	NP	I-M 383 387	[15]	[4]	LOWERCASE	allAlpha
on	IN	OTHER	O 388 390	[16]	[2]	LOWERCASE	allAlpha
only	RB	OTHER	O 391 395	[17]	[4]	LOWERCASE	allAlpha
one	CD	OTHER	O 396 399	[18]	[3]	LOWERCASE	allAlpha
surface.	NN	NP	B-M 400 407	[19]	[8]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 409 412	[1]	[3]	CAPITALIZED	allAlpha
subsequent	JJ	OTHER	O 413 423	[2]	[10]	LOWERCASE	allAlpha
swelling	VBG	VP	B-P 424 432	[3]	[8]	LOWERCASE	allAlpha
of	IN	OTHER	I-P 433 435	[4]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	I-P 436 439	[5]	[3]	LOWERCASE	allAlpha
PAA	NN	NP	B-P 440 443	[6]	[3]	CAPITALIZED	allAlpha
inter-penetrating	JJ	NP	I-P 444 461	[7]	[17]	LOWERCASE	ContainSymbol
network	NN	NP	I-P 462 469	[8]	[7]	LOWERCASE	allAlpha
(IPN)	NN	NP	O 470 475	[9]	[5]	LOWERCASE	ContainSymbol
in	IN	PP	O 476 478	[10]	[2]	LOWERCASE	allAlpha
elevated	JJ	NP	B-M 479 487	[11]	[8]	LOWERCASE	allAlpha
pH	NN	NP	I-M 488 490	[12]	[2]	LOWERCASE	allAlpha
causes	VBZ	VP	O 491 497	[13]	[6]	LOWERCASE	allAlpha
a	DT	OTHER	O 498 499	[14]	[1]	LOWERCASE	allAlpha
swelling	VBG	VP	B-P 500 508	[15]	[8]	LOWERCASE	allAlpha
differential	NN	NP	I-P 509 521	[16]	[12]	LOWERCASE	allAlpha
across	IN	OTHER	O 522 528	[17]	[6]	LOWERCASE	allAlpha
the	DT	OTHER	O 529 532	[18]	[3]	LOWERCASE	allAlpha
film,	NN	NP	B-M 533 537	[19]	[5]	LOWERCASE	ContainSymbol
causing	VBG	VP	O 539 546	[20]	[7]	LOWERCASE	allAlpha
it	PRP	OTHER	O 547 549	[21]	[2]	LOWERCASE	allAlpha
to	TO	OTHER	O 550 552	[22]	[2]	LOWERCASE	allAlpha
roll	VB	VP	B-P 553 557	[23]	[4]	LOWERCASE	allAlpha
to	TO	OTHER	O 558 560	[24]	[2]	LOWERCASE	allAlpha
accommodate	VB	VP	B-T 561 572	[25]	[11]	LOWERCASE	allAlpha
the	DT	OTHER	I-T 573 576	[26]	[3]	LOWERCASE	allAlpha
difference	NN	NP	I-T 577 587	[27]	[10]	LOWERCASE	allAlpha
in	IN	PP	I-T 588 590	[28]	[2]	LOWERCASE	allAlpha
surface	NN	NP	I-T 591 598	[29]	[7]	LOWERCASE	allAlpha
area	NN	NP	I-T 599 603	[30]	[4]	LOWERCASE	allAlpha
between	IN	OTHER	I-T 604 611	[31]	[7]	LOWERCASE	allAlpha
the	DT	OTHER	I-T 612 615	[32]	[3]	LOWERCASE	allAlpha
two	CD	OTHER	I-T 616 619	[33]	[3]	LOWERCASE	allAlpha
surfaces.	NN	NP	B-M 620 628	[34]	[9]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 630 633	[1]	[3]	CAPITALIZED	allAlpha
surface	NN	NP	O 634 641	[2]	[7]	LOWERCASE	allAlpha
functionalization	NN	NP	O 642 659	[3]	[17]	LOWERCASE	allAlpha
and	CC	OTHER	O 660 663	[4]	[3]	LOWERCASE	allAlpha
patterning	NN	NP	O 664 674	[5]	[10]	LOWERCASE	allAlpha
stages	NNS	NP	O 675 681	[6]	[6]	LOWERCASE	allAlpha
are	VBP	VP	O 682 685	[7]	[3]	LOWERCASE	allAlpha
thus	RB	OTHER	O 686 690	[8]	[4]	LOWERCASE	allAlpha
combined	VBN	VP	O 691 699	[9]	[8]	LOWERCASE	allAlpha
into	IN	OTHER	O 700 704	[10]	[4]	LOWERCASE	allAlpha
one	CD	OTHER	O 705 708	[11]	[3]	LOWERCASE	allAlpha
photolithographic	JJ	NP	B-P 709 726	[12]	[17]	LOWERCASE	allAlpha
operation.	NN	NP	I-P 727 736	[13]	[10]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 738 741	[1]	[3]	CAPITALIZED	allAlpha
net	JJ	NP	O 742 745	[2]	[3]	LOWERCASE	allAlpha
result	NN	NP	O 746 752	[3]	[6]	LOWERCASE	allAlpha
is	VBZ	VP	O 753 755	[4]	[2]	LOWERCASE	allAlpha
a	DT	OTHER	O 756 757	[5]	[1]	LOWERCASE	allAlpha
method	NN	NP	O 758 764	[6]	[6]	LOWERCASE	allAlpha
of	IN	PP	O 765 767	[7]	[2]	LOWERCASE	allAlpha
producing	VBG	VP	B-P 768 777	[8]	[9]	LOWERCASE	allAlpha
environmentally	RB	OTHER	I-P 778 793	[9]	[15]	LOWERCASE	allAlpha
triggered	JJ	NP	I-P 794 803	[10]	[9]	LOWERCASE	allAlpha
self-folding	NN	NP	I-P 804 816	[11]	[12]	LOWERCASE	ContainSymbol
all	DT	OTHER	I-P 817 820	[12]	[3]	LOWERCASE	allAlpha
hydrogel	NN	NP	I-P 821 829	[13]	[8]	LOWERCASE	allAlpha
scaffolds	NNS	NP	I-P 830 839	[14]	[9]	LOWERCASE	allAlpha
by	IN	PP	O 840 842	[15]	[2]	LOWERCASE	allAlpha
a,	NN	NP	O 843 844	[16]	[2]	LOWERCASE	ContainSymbol
to	TO	OTHER	O 846 848	[17]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 849 852	[18]	[3]	LOWERCASE	allAlpha
authorsâ€™	FW	OTHER	O 853 861	[19]	[8]	LOWERCASE	ContainSymbol
knowledge,	FW	OTHER	O 862 871	[20]	[10]	LOWERCASE	ContainSymbol
novel	JJ	NP	B-T 873 878	[21]	[5]	LOWERCASE	allAlpha
use	NN	NP	I-T 879 882	[22]	[3]	LOWERCASE	allAlpha
of	IN	PP	I-T 883 885	[23]	[2]	LOWERCASE	allAlpha
sacrificial	JJ	NP	I-T 886 897	[24]	[11]	LOWERCASE	allAlpha
layer	NN	NP	I-T 898 903	[25]	[5]	LOWERCASE	allAlpha
embossing.	NN	NP	I-T 904 913	[26]	[10]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 915 918	[1]	[3]	CAPITALIZED	allAlpha
patterned	VBN	VP	B-M 919 928	[2]	[9]	LOWERCASE	allAlpha
hydrogel	NN	NP	I-M 929 937	[3]	[8]	LOWERCASE	allAlpha
films	NNS	NP	I-M 938 943	[4]	[5]	LOWERCASE	allAlpha
can	MD	OTHER	O 944 947	[5]	[3]	LOWERCASE	allAlpha
be	VB	VP	O 948 950	[6]	[2]	LOWERCASE	allAlpha
triggered	VBN	VP	B-P 951 960	[7]	[9]	LOWERCASE	allAlpha
consecutively	RB	OTHER	I-P 961 974	[8]	[13]	LOWERCASE	allAlpha
allowing	VBG	VP	O 975 983	[9]	[8]	LOWERCASE	allAlpha
for	IN	PP	O 984 987	[10]	[3]	LOWERCASE	allAlpha
successive	JJ	NP	O 988 998	[11]	[10]	LOWERCASE	allAlpha
rolling	NN	NP	B-P 999 1006	[12]	[7]	LOWERCASE	allAlpha
and	CC	OTHER	O 1007 1010	[13]	[3]	LOWERCASE	allAlpha
unrolling	NN	NP	B-P 1011 1020	[14]	[9]	LOWERCASE	allAlpha
depending	VBG	VP	O 1021 1030	[15]	[9]	LOWERCASE	allAlpha
on	IN	OTHER	O 1031 1033	[16]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 1034 1037	[17]	[3]	LOWERCASE	allAlpha
aqueous	JJ	NP	B-M 1038 1045	[18]	[7]	LOWERCASE	allAlpha
pH.	NN	NP	I-M 1046 1048	[19]	[3]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 1050 1053	[1]	[3]	CAPITALIZED	allAlpha
choice	NN	NP	O 1054 1060	[2]	[6]	LOWERCASE	allAlpha
of	IN	PP	O 1061 1063	[3]	[2]	LOWERCASE	allAlpha
PEGDMA	NN	NP	B-M 1064 1070	[4]	[6]	CAPITALIZED	allAlpha
hydrogel	NN	NP	I-M 1071 1079	[5]	[8]	LOWERCASE	allAlpha
provides	VBZ	VP	O 1080 1088	[6]	[8]	LOWERCASE	allAlpha
a	DT	OTHER	O 1089 1090	[7]	[1]	LOWERCASE	allAlpha
versatile	JJ	NP	B-M 1091 1100	[8]	[9]	LOWERCASE	allAlpha
platform	NN	NP	I-M 1101 1109	[9]	[8]	LOWERCASE	allAlpha
for	IN	OTHER	I-M 1110 1113	[10]	[3]	LOWERCASE	allAlpha
creating	VBG	VP	I-M 1114 1122	[11]	[8]	LOWERCASE	allAlpha
a	DT	OTHER	I-M 1123 1124	[12]	[1]	LOWERCASE	allAlpha
variety	NN	NP	I-M 1125 1132	[13]	[7]	LOWERCASE	allAlpha
of	IN	PP	I-M 1133 1135	[14]	[2]	LOWERCASE	allAlpha
hydrogel	NN	NP	B-M 1136 1144	[15]	[8]	LOWERCASE	allAlpha
scaffolds,	NN	NP	I-M 1145 1154	[16]	[10]	LOWERCASE	ContainSymbol
and	CC	OTHER	O 1156 1159	[17]	[3]	LOWERCASE	allAlpha
while	IN	OTHER	O 1160 1165	[18]	[5]	LOWERCASE	allAlpha
being	VBG	VP	O 1166 1171	[19]	[5]	LOWERCASE	allAlpha
non-fouling	JJ	OTHER	O 1172 1183	[20]	[11]	LOWERCASE	ContainSymbol
and	CC	OTHER	O 1184 1187	[21]	[3]	LOWERCASE	allAlpha
nontoxic	JJ	OTHER	O 1188 1196	[22]	[8]	LOWERCASE	allAlpha
it	PRP	OTHER	O 1197 1199	[23]	[2]	LOWERCASE	allAlpha
is	VBZ	VP	O 1200 1202	[24]	[2]	LOWERCASE	allAlpha
permeable	JJ	OTHER	O 1203 1212	[25]	[9]	LOWERCASE	allAlpha
to	TO	OTHER	O 1213 1215	[26]	[2]	LOWERCASE	allAlpha
proteins.	NN	NP	B-M 1216 1224	[27]	[9]	LOWERCASE	ContainSymbol

Furthermore	RB	OTHER	O 1226 1237	[1]	[11]	CAPITALIZED	allAlpha
PEGDMA	NN	NP	B-M 1238 1244	[2]	[6]	CAPITALIZED	allAlpha
can	MD	OTHER	O 1245 1248	[3]	[3]	LOWERCASE	allAlpha
be	VB	VP	O 1249 1251	[4]	[2]	LOWERCASE	allAlpha
modified	VBN	VP	O 1252 1260	[5]	[8]	LOWERCASE	allAlpha
to	TO	OTHER	O 1261 1263	[6]	[2]	LOWERCASE	allAlpha
produce	VB	VP	B-T 1264 1271	[7]	[7]	LOWERCASE	allAlpha
biodegradable	JJ	OTHER	I-T 1272 1285	[8]	[13]	LOWERCASE	allAlpha
and	CC	OTHER	I-T 1286 1289	[9]	[3]	LOWERCASE	allAlpha
cell	NN	NP	I-T 1290 1294	[10]	[4]	LOWERCASE	allAlpha
adhesive	NN	NP	I-T 1295 1303	[11]	[8]	LOWERCASE	allAlpha
hydrogels	NNS	NP	B-M 1304 1313	[12]	[9]	LOWERCASE	allAlpha
for	IN	OTHER	O 1314 1317	[13]	[3]	LOWERCASE	allAlpha
a	DT	OTHER	O 1318 1319	[14]	[1]	LOWERCASE	allAlpha
variety	NN	NP	O 1320 1327	[15]	[7]	LOWERCASE	allAlpha
of	IN	PP	O 1328 1330	[16]	[2]	LOWERCASE	allAlpha
biomedical	JJ	NP	B-T 1331 1341	[17]	[10]	LOWERCASE	allAlpha
applications.	NN	NP	I-T 1342 1354	[18]	[13]	LOWERCASE	ContainSymbol

